Emerging pharmaceutical markets Argentina and Mexico

Latin American countries have attracted a lot of attention recently. With their economies currently stable, their geographic location and low-cost is ideal for investors. In addition, having such a high and varied population eases recruitment for clinical trials, and the demographics show there is a very high need for pharmaceuticals.

Scope

Overview of the key trends driving the pharmaceutical market growth Analysis of key healthcare system characteristics impacting the pharmaceutical market Analysis of pharmaceutical market dynamics in Argentina and Mexico Overview of key pharmaceutical players in Argentina and Mexico

Highlights

Although both the Argentinean and the Mexican markets have been growing, their growth is attributed to different reasons. The Argentinean pharmaceutical market has been growing mainly based on growing sales volume, while growth of the Mexican market is mainly driven by growing prices. The Mexican market is dominated by foreign companies with few domestic players. The Argentinean market is dominated by domestic branded generics firms, due to the economic crisis which led to many foreign companies to sell their plants in Argentina, thus allowing the domestic firms to gain over their market share. Sales of pharmaceutical categories in both countries are very similar to the West thus opening growth opportunities for foreign companies. However, sales of oncology drugs are low in both countries; and Mexico has higher sales of anti-infective drugs indicating that these markets still have scope for further development and growth.

Reasons to Purchase

Identify the healthcare needs in Argentina and Mexico Understand the barriers and drivers for entering these markets Gain insight into pharmaceutical dynamics of Argentina and Mexico.

12-Mar-08 Format: PDF & SlidePack Pages: 106

Table of Contents
Price: $7,600.00 / GBP3,952.00